donanemab

popped balloon thumb tack pop burst
Biotech

Lilly faces phase 2 failure of tau-targeting med

The confetti is still flying from the approval of donanemab, but Eli Lilly is yet again facing the harsh reality of the Alzheimer's disease.
alzheimers brain neurodegenerative memory head

AbbVie axes Alzheimer's program amid 'evolving landscape'

Jul 25, 2024 10:49am
brain alzheimers dementia neuroscience gears thought think

Lilly's donanemab sails through FDA meeting with 2 yes votes

Jun 10, 2024 5:11pm
brain amyloid alzheimers strings detailed web complicated thought

FDA lays out donanemab concerns, Lilly vigorously defends safety

Jun 6, 2024 10:55am
calendar hour glass wait delay months

Lilly gets a date with FDA to discuss Alzheimer's med donanemab

May 7, 2024 10:20am
slipstream contrails aircraft airplanes sky fly miss cross

Lilly glides out of Leqembi slipstream with FDA meeting request

Apr 17, 2024 5:00am